ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Investigating Role of Early VTE Chemoprophylaxis in Kidney Transplant

D. Kendrick,1 E. Kudlaty,1 A. Kim,1 P. Moorehead,1 J. Augustine,2 E. Sanchez,2 V. Kashyap,1 K. Woodside.2

1Vascular Surgery, University Hospitals-Case Medical Center, Cleveland, OH
2Transplant Institute, University Hospitals-Case Medical Center, Cleveland, OH.

Meeting: 2015 American Transplant Congress

Abstract number: C229

Keywords: Anticoagulation, Blood transfusion, Kidney transplantation, Vascular disease

Session Information

Date: Monday, May 4, 2015

Session Name: Poster Session C: Surgical Issues/Ureteral Complications

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Related Abstracts
  • Efficacy of Low Dose Chemoprophylaxis for Coccidioidomycosis Infection in Liver Transplantation Recipients
  • The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disease (PTLD) in Solid Organ Transplant Recipients: A Systematic Review

Objective: Our objective was to determine whether the rate of venothromboembolic events (VTE) varied with early versus delayed prophylaxis administration. Associated bleeding complications were also examined.

Methods: We performed a single institution retrospective chart-review to evaluate all isolated kidney transplants performed from 6/2010 -7/2013, excluding liver/pancreas co-transplant patients. Timing of chemoprophylaxis administration was recorded and patients were grouped in two cohorts, based on pre- vs. post-operative administration. Other data included total number of units of red blood cells (pRBCs) transfused within 2 weeks of the operation, and14-day transfusion rate, 90-day VTE rates, and major bleeding complications were also noted. Statistical analyses were conducted using unpaired t-test for continuous variables and Fischer exact test for proportional event rates.

Results: A total of 254 patient records were examined comprised of 32% living donor transplants, 43% deceased standard criteria, 10% deceased expanded criteria and 15% donation after cardiac death. 89% of patients received a chemoprophylaxis regimen including 5000 U of subcutaneous heparin TID. Additional orders for sequential compression devices while in bed are standard for all transplant recipients. The 90-day rate of VTE in the pre-op prophylaxis cohort vs. those receiving prophylaxis post-operatively was 1.5% and 5.4% respectively (RR 0.28, 95% CI 0.04 – 2.21, p=0.28). There was a non-significant difference in major bleeding event rates between pre and post-operative heparin groups, 13.8%% and 9.0% respectively (RR 2.37, 95% CI 0.71-3.27, p=0.34). The mean number of units of pRBCs transfused within 2 weeks of operation in the pre-op and post-op cohort was 0.99 v 0.81 respectively, p= 0.51.

Conclusion: In this study, early administration of VTE chemoprophylaxis in isolated kidney transplant patients resulted in tendency towards increased risk of major bleeding complications and number of blood transfusions with a three-fold difference in VTE prevention. The study is underpowered to definitively recommend a chemoprophylaxis treatment strategy, but the trends identified suggest that further study is warranted.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kendrick D, Kudlaty E, Kim A, Moorehead P, Augustine J, Sanchez E, Kashyap V, Woodside K. Investigating Role of Early VTE Chemoprophylaxis in Kidney Transplant [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/investigating-role-of-early-vte-chemoprophylaxis-in-kidney-transplant/. Accessed April 20, 2021.

« Back to 2015 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
    • Assessment of Anti-A and Anti-B Antibody Titers in Different IVIG Preparations: Correlation with Risk for Hemolysis

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy | Terms of Use

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.